ClinicalTrials.gg
CompletedNCT07880483Enzyme T/PUpdated Oct 21, 2026

Comparision of Enzymatic and Active Salt Toothpaste

An interventional study of Enzyme toothpaste and active salt toothpaste in Gingivitis; Chronic, Gingivitis and Periodontal Diseases and Dental Plaque, sponsored by Uttar Pradesh University of medical sciences. Completed at 1 site in India. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Uttar Pradesh University of medical sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 3 months after the study started (first participant enrolled Jul 2021, registered Oct 2026).
Updated Oct 21, 2026Eligibility revisedPrimary outcomes revised+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Dental plaque is a major etiological factor in the development of gingivitis. Mechanical plaque control through toothbrushing is essential for maintaining oral hygiene, while toothpaste formulations containing active ingredients may provide additional benefits in controlling plaque accumulation and gingival inflammation. Enzymatic toothpaste containing the lactoperoxidase system and salt-containing toothpaste incorporating sodium chloride and sodium bicarbonate have been investigated for their potential effects on plaque control and gingival health.

This randomized, prospective, double-blind, parallel-group clinical study evaluated and compared the efficacy of enzymatic toothpaste, active salt toothpaste, and standard fluoridated toothpaste in reducing dental plaque and gingival inflammation following non-surgical periodontal therapy (NSPT).

The study was conducted in the Department of Periodontology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, Uttar Pradesh, India, from July 2021 to December 2022. The study protocol received approval from the Institutional Ethics Committee of Uttar Pradesh University of Medical Sciences (approval number: 222/2020-21). Written informed consent was obtained from all participants before study procedures.

A total of 93 eligible participants with mild to moderate gingivitis were enrolled and randomly allocated to three groups. All participants initially received non-surgical periodontal therapy and used standard fluoridated toothpaste for a four-week pretreatment period. Following the pretreatment period, baseline clinical assessments were performed, and participants received the toothpaste assigned to the respective study group.

Group I received enzymatic toothpaste (Curaprox Enzycal 950), containing amyloglucosidase, glucose oxidase, lactoperoxidase, and potassium thiocyanate. Group II received active salt toothpaste (Colgate Active Salt), containing sodium chloride and sodium bicarbonate. Group III received standard fluoridated toothpaste (Colgate Strong Teeth), containing calcium carbonate and sodium monofluorophosphate.

Participants were instructed to brush their teeth for two minutes twice daily using the allocated toothpaste for 12 weeks. The use of mouthwashes, interdental aids, and other antiplaque products was restricted during the pretreatment and intervention periods.

Clinical assessments were performed at baseline, following the four-week pretreatment period, and after the 12-week intervention period, as specified in the study protocol. The clinical parameters included the Turesky-Gilmore-Glickman modification of the Quigley-Hein Plaque Index (TQHPI), the Gingival Index (GI), and probing pocket depth (PPD).

The collected data were analyzed using SPSS software, version 20.0. Within-group and between-group comparisons were performed using appropriate parametric and non-parametric statistical tests. Statistical significance was set at p less than 0.05.

Read the detailed description

Introduction A diverse microbiota of more than 700 species of bacteria and other microorganisms inhabits the oral cavity. These are present in an organized form as dental plaque or biofilm. These commensal microorganisms live in harmony with the host and perform a number of important functions, such as preventing the colonization of pathogenic microorganisms. However, sometimes this commensalism relationship might collapse, leading to conditions including gingivitis, periodontitis and dental caries. This could be prevented by proper plaque control. Plaque control involves the utilization of chemical agents and mechanical techniques. Mechanical plaque control like toothbrushing is the key for maintaining oral hygiene at personal level. Despite the effectiveness of adequate mechanical removal of plaque having been demonstrated, only 11-51% of people clean their teeth properly . Chemical plaque control agents like toothpastes and mouthwashes are therefore required as an adjunct to mechanical plaque control. Triclosan, herbs, enzymes, chlorhexidine, metal ions, salt etc are incorporated in the toothpaste as an active agent.

In last decade, an in-vitro study on enzymatic toothpaste (active ingredients lactoperoxidase, amyloglucosidase, and glucose oxidase) has shown to strengthen the oral cavity's natural antibacterial system by raising salivary levels of hydrogen peroxide, lysozyme, and hypothiocyanite while also reducing the survival of oral bacterial biofilms. The similar enzyme containing toothpaste in a sequencing study on dental plaque samples has shown significant shift in the ecology of microbiome (at species level). There was increase in 12 taxa of periodontal health promoting microbes like Neisseria spp. and decrease in 10 taxa of pathogenic microbe like Treponema spp. Several clinical studies have shown encouraging results of the enzymatic toothpaste in reducing dental plaque and gingivitis. , , Another important active ingredient that is known for its effect as an anti-inflammatory action is salt (including sodium chloride and sodium bicarbonate). The recent studies on the salt have shown that rinsing with NaCl solution can stimulate gingival fibroblast migration and thereby enhances wound healing. A randomized clinical trial evaluating the effect of sodium bicarbonate containing toothpaste on mild to moderate gingivitis patient has shown to improve the gingival health and bleeding. Systemic review on salt containing toothpaste concluded promising result obtained on controlling plaque and reduction in bleeding score.

The objective of the current study was to evaluate and compare the efficacy of enzymatic toothpaste (lactoperoxidase, amyloglucosidase, and glucose oxidase) and active salt toothpaste (sodium bicarbonate and sodium chloride) in the reduction of dental plaque and gingivitis in North Indian population.

Review of literature Dental plaque is defined clinically as a structured resilient, yellow greyish substance that adheres tenaciously to the intraoral hard surfaces, including removal and fixed restorations.

Chemotherapeutic agents could also affect gingivitis directly if they possessed anti-inflammatory or prostaglandin synthetase inhibitory activity (Goodson). As a consequence many antimicrobial compounds have been added in the toothpaste or as mouthrinses with the aim of preventing or reducing plaque.

Enzymes and salt are few of the active ingredients that are added in the toothpaste. Previous studies have shown that the inclusion of enzymes in the mouthrinses and dentifrices reduce plaque and gingivitis. The enzymes that are most effective clinically have, as their active ingredients, Amyloglucosidase, Glucoseoxidase and Lactoperoxidase.

Hugoson A et al. conducted a study to test the efficiency of Lactoperoxidase in the prevention of plaque accumulation, gingivitis and dental caries. They used twenty-two dental students. The individuals in the test group rinsed with 10ml of of a test solution containing Amyloglucosidase, Glucoseoxidase 3 times a day. The controls rinsed with a placebo solution. They were refrained from the daily oral hygiene routine. At the end of the experimental period there were highly significant differences in caries distribution between the test and control groups, with a more pronounced aggravation of the caries lesions in the control group compared with the test group.

Afseth J and Rolla G did a study to test the efficiency of enzymatic toothpaste over SnF2 containing toothpaste. They found that the enzymatic toothpaste did not reduce the acidogenicity of dental plaque in vivo neither did it reduce plaque formation in a test panel. A toothpaste containing SnF2 showed measurable effect in both respects.

Salt (sodium chloride and sodium bicarbonate) are added as an active ingredient in the toothpaste. To find out the mechanism of salt on gingival healing, Nam Cong-Nhat Huynh et al.16 did a study and found out that rinsing with 1.8% NaCl significantly up regulate the expression of type-I collagen and fibronectin. They found that a high NaCl concentration especially with long term exposure causes DNA damage and inhibits its repair This may lead to apoptosis or may affect cellular survival and their function both in cell culture and in vivo.

Material and method

This randomized, prospective, double-blind, parallel-group clinical study evaluated and compared the efficacy of enzymatic toothpaste, active salt toothpaste, and standard fluoridated toothpaste in reducing dental plaque and gingival inflammation following non-surgical periodontal therapy (NSPT).

The study was conducted in the Department of Periodontology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, Uttar Pradesh, India, from July 2021 to December 2022. The study protocol received approval from the Institutional Ethics Committee of Uttar Pradesh University of Medical Sciences (approval number: 222/2020-21). Written informed consent was obtained from all participants before study procedures.

A total of 93 eligible participants with mild to moderate gingivitis were enrolled and randomly allocated to three groups. All participants initially received non-surgical periodontal therapy and used standard fluoridated toothpaste for a four-week pretreatment period. Following the pretreatment period, baseline clinical assessments were performed, and participants received the toothpaste assigned to the respective study group.

Statistical analysis A Microsoft Excel spreadsheet was used to enter the data, and any discrepancies were looked at. Data analyses were done using SPSS version 20.0 and non parametric test (Wilcoxon signed rank test, Kruskal-wallis test, Mann-Whitney Test) and parametric test (Paired t-test, ANOVA, Turkey's post hoc analysis) used for comparing means in different group of individual before and after interval. Tables and figures were used to display the summarized data. Level of statistical significance was set at p-value less than 0.05, confidence level at 95% and power at 80%

02

Conditions studied

  • Gingivitis; Chronic
  • Gingivitis and Periodontal Diseases
  • Dental Plaque

Keywords

  • Comparative study
  • Toothpaste
  • Lactoperoxidase system
03

In context

Gingivitis

609 studies on the registry are indexed under Gingivitis; 107 are open to participants now.

This study's enrollment of 93 is above the median of 63 across 494 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

This is the only study on the registry with Uttar Pradesh University of medical sciences as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects with mild to moderate gingivitis
  • Systemically healthy patients
  • Subjects with less than 20 permanent teeth remaining.

Exclusion criteria

Exclusion Criteria:

  • Smoker
  • Pregnant or lactating female
  • Patients who have undergone non-surgical periodontal therapy in last 6 months.
  • Subjects who have received any antibiotic and anti-inflammatory therapy within three months.
  • Patients using enzymatic and active salt toothpaste in the last 6 months.
  • Not good dexterity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Group II

    the patients received allocated toothpaste i.e., Active salt toothtpaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks.

    Drug: active salt toothpaste

  • Placebo comparator
    Group III

    the patients received allocated toothpaste i.e., Standard Fluoridated toothpaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks.

    Drug: standard fluoridated toothpaste

  • Experimental
    Group I

    the patients received allocated toothpaste, i.e., Enzymatic Toothpaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks

    Drug: Enzyme toothpaste

Interventions

  • DrugEnzyme toothpaste

    4 weeks After non surgical periodontal therapy the patient randomly allocated to the groups. the patient of group I received enzymatic toothpoaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks after evaluating the baseline clinical parameters. During the period, patients were asked not to use mouthwash, interdental aids or any other antiplaque products. After 12 weeks of use of allocated toothpaste, patients returned to the department for final clinical assessment. The data obtained were statistically analysed.

    Also known as: enzyme containing toothpaste and active salt toothpaste, standard fluoridated toothpaste

  • Drugactive salt toothpaste

    4 weeks After non surgical periodontal therapy the patient randomly allocated to the groups. the patient of group II received active salt toothpaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks after evaluating the baseline clinical parameters. During the period, patients were asked not to use mouthwash, interdental aids or any other antiplaque products. After 12 weeks of use of allocated toothpaste, patients returned to the department for final clinical assessment. The data obtained were statistically analysed.

  • Drugstandard fluoridated toothpaste

    4 weeks After non surgical periodontal therapy the patient randomly allocated to the groups. the patient of group III received standard fluoridated toothpaste and were asked to brush for 2 minutes, twice a day for a period of 12 weeks after evaluating the baseline clinical parameters. During the period, patients were asked not to use mouthwash, interdental aids or any other antiplaque products. After 12 weeks of use of allocated toothpaste, patients returned to the department for final clinical assessment. The data obtained were statistically analysed.

06

What researchers measure

Primary outcomes

  1. Gingival Index

    Gingival index was developed by Loe H and Sillness P in 1963, solely on the purpose of purpose of assessing the severity of gingivitis and its location in 4 possible areas by examining only the qualitative changes of the gingival soft tissue. Instrument used- mouth mirror, periodontal probe Interpretation- Mild gingivitis- 0.1-1.0, Moderate gingivitis- 1.1- 2.0, Severe gingivitis- 2.1-3.0 Minimum score 0, maximum score 3. Higher score means worse outcome

    Time frame: 12 weeks

  2. Plaque Index

    Quigley-Hein has given the plaque index in 1962 that focused on plaque measurement on the gingival third of tooth surface only on the facial surfaces of anterior teeth. Quigley-Hein plaque index was modified by Turesky, Gilmore and Glickman in 1970. Plaque is assessed on the labial/buccal and lingual surfaces of all the teeth after using a disclosing agent (Quigley-Hein used basic fuchsin). Instrument used- Mouth mirror, Disclosing agent Interpretation: Low: 0-1, High: 2 or more Minimum score 0, maximum score 5. higher score means worse outcome

    Time frame: 12 weeks

Secondary outcomes

  1. Probing pocket depth

    Probing depth measured from gingival margin to the base of the periodontal pocket using UNC-15 periodontal probe (Hu-friedy 6, Mfd.Co., LLC, Rockwell, Chicago, USA). Minimum score 0, maximum score 3. higher score means worse outcome

    Time frame: 12 weeks

07

Study locations

1 site
  • Uttar Pradesh University of Medical Sciences
    Etāwah, Uttar Pradesh 206130, India
08

References and documents

Publications

  • Sanz M, Serrano J, Iniesta M, Santa Cruz I, Herrera D. Antiplaque and antigingivitis toothpastes. Monogr Oral Sci. 2013;23:27-44. doi: 10.1159/000350465. Epub 2013 Jun 28. PubMed 23817058 ↗
  • Bowen WH. Nature of plaque. Oral Sci Rev. 1976;9:3-21. No abstract available. PubMed 9613 ↗
  • Deo PN, Deshmukh R. Oral microbiome: Unveiling the fundamentals. J Oral Maxillofac Pathol. 2019 Jan-Apr;23(1):122-128. doi: 10.4103/jomfp.JOMFP_304_18. PubMed 31110428 ↗
  • Barnett ML. The rationale for the daily use of an antimicrobial mouthrinse. J Am Dent Assoc. 2006 Nov;137 Suppl:16S-21S. doi: 10.14219/jada.archive.2006.0408. PubMed 17035671 ↗

Study documents

  • Study protocol · Dec 31, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Patient identifiers will not be disclosed including ipd number

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2021 to primary completion in Dec 2022, 17 months.

Of 203 non-industry interventional studies with no phase under Gingivitis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 19. This study's 17 months is above that.

Counting every sponsor, half of 255 studies reached it within 7 months; a quarter within 3 and three quarters within 16.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 19, 2026
StartActual
Jul 1, 2021
Primary completionActual
Dec 31, 2022
CompletionActual
Dec 31, 2022
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility and primary outcomes
Registered
First appeared on the registry
Oct 19, 2026
Show all 2 updates
  1. Oct 21, 2026
    Eligibility Criteria revised
    Primary outcomes Revised (4 changes)
    + 2 other changes: description and secondary outcomes
  2. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07880483
Lead sponsor
Uttar Pradesh University of medical sciences
Responsible party
Tabassum (JUNIOR RESIDENT, Uttar Pradesh University of medical sciences) — Principal investigator
First posted
Oct 19, 2026
Start date
Jul 1, 2021
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Oct 21, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion